Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
- 31 March 2000
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (3) , 428-435
- https://doi.org/10.1016/s0190-9622(00)90214-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgarisJournal of Clinical Investigation, 1999
- Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells.The Journal of Experimental Medicine, 1995
- Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basisNature Medicine, 1995
- An Extension to WittkowskiJournal of the American Statistical Association, 1992
- Adhesion receptors of the immune systemNature, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Friedman-Type Statistics and Consistent Multiple Comparisons for Unbalanced Designs with Missing DataJournal of the American Statistical Association, 1988
- Regulatory properties of LFA-1 α and β chains in human T-lymphocyte activationNature, 1988
- Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.The Journal of Experimental Medicine, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978